XML 16 R4.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Interim Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Operating expenses        
General and administrative $ 2,859 $ 3,248 $ 8,258 $ 9,447
Research and development 11,870 10,283 30,283 33,657
Total operating expenses 14,729 13,531 38,541 43,104
Operating loss (14,729) (13,531) (38,541) (43,104)
Other income (expense)        
Grant income 0 0 0 25
Research and development incentive income 526 565 1,591 2,048
Interest income, net 1,796 1,828 5,561 4,561
Other financing expense 0 0 0 (964)
Foreign exchange gain (loss) 67 (101) 72 146
Gain on settlement of accounts payable 59 0 59 0
Total other income, net 2,448 2,292 7,283 5,816
Net loss before provision for income taxes (12,281) (11,239) (31,258) (37,288)
Income tax recovery (expense), current 67 (41) (124) (71)
Net loss and comprehensive loss $ (12,214) $ (11,280) $ (31,382) $ (37,359)
Net Loss per share        
Net Loss per share, Basic $ (0.14) $ (0.14) $ (0.38) $ (0.47)
Net Loss per share, Diluted $ (0.14) $ (0.14) $ (0.38) $ (0.47)
Weighted average number of shares outstanding        
Weighted average number of shares outstanding, Basic 84,535,328 80,875,235 83,022,330 79,051,038
Weighted average number of shares outstanding, Diluted 84,535,328 80,875,235 83,022,330 79,051,038